Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader–Willi syndrome, Bardet–Biedl syndrome and craniopharyngioma versus anorexia nervosa

por Vlaardingerbroek, H, van den Akker, E L T, Hokken-Koelega, A C S
Publicado 2021

Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial

por Kuppens, R. J., Mahabier, E. F., Bakker, N. E., Siemensma, E. P. C., Donze, S. H., Hokken-Koelega, A. C. S.
Publicado 2016

GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism

por Tauber, M, Ester, W, Auriol, F, Molinas, C, Fauvel, J, Caliebe, J, Nugent, T, Fryklund, L, Ranke, M B, Savage, M O, Clark, A J L, Johnston, L B, Hokken-Koelega, A C S
Publicado 2007

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome

por Kuppens, R. J., Diène, G., Bakker, N. E., Molinas, C., Faye, S., Nicolino, M., Bernoux, D., Delhanty, P. J. D., van der Lely, A. J., Allas, S., Julien, M., Delale, T., Tauber, M., Hokken-Koelega, A. C. S.
Publicado 2015